ESGL Holdings Limited (ESGLW) 株式分析

企業概要

ESGL Holdings Limited operates primarily as a waste management, treatment, and recycling enterprise through its subsidiary, Environmental Solutions (Asia) Pte. Ltd. The company focuses on the collection and recycling of both hazardous and non-hazardous industrial waste derived from pharmaceutical, semiconductor, petrochemical, and related sectors. Although specific sector and industry classifications are not publicly disclosed in the available data, the operational scope suggests a specialized niche within environmental services and industrial waste processing. In terms of scale, the company employs 79 individuals and reports a trailing twelve-month revenue of $5.33 million. The absence of a listed market cap value indicates that the equity valuation is either not currently traded on major exchanges or the market capitalization data is unavailable, which limits the ability to directly compare the company's revenue scale against traditional public market peers. Consequently, the revenue figure of $5.33 million serves as the primary indicator of the company's operational size, reflecting a small-cap profile typical for specialized industrial service providers rather than large-scale conglomerates.

財務健全性

The company reported a trailing twelve-month revenue of $5.33 million, yet it posted a net income loss of $2,729,039 and an EBITDA loss of $1,811,999. The significant disparity between the positive revenue of $5.33 million and the substantial negative net income reveals a cost structure where operating expenses and other deductions far exceed gross earnings, indicating intense pressure on profitability. Free cash flow stands at -$5,031,612, which signifies that the company is burning cash rather than generating liquidity from its operations, thereby constraining its financial flexibility and reliance on external capital for ongoing activities. Margin analysis shows a gross margin of 53.0%, suggesting that the core waste processing activities retain a healthy portion of revenue before direct costs, while the operating margin of -102.2% and profit margin of -51.2% demonstrate severe inefficiencies in overhead control and overall profitability. On the balance sheet, the company holds cash of $312,547 against total debt of $6.19 million, resulting in a debt-to-equity ratio of 45.76, which points to a highly leveraged position rather than a conservative one. The current ratio is 0.18, indicating that current assets are insufficient to cover current liabilities, highlighting a critical shortage in short-term liquidity that could pose risks if obligations were to come due immediately. Furthermore, the return on equity is -23.2% and the return on assets is -7.9%, metrics that reveal that management's capital allocation has not yet generated positive returns for shareholders or asset owners.

バリュエーション評価

Trailing P/E, forward P/E, and price-to-sales ratios are not available (N/A) for ESGL Holdings Limited, which implies that standard earnings-based valuation multiples cannot be calculated due to the company's lack of positive earnings. The price-to-book ratio is recorded at 0.19, indicating that the market values the company's equity at less than 20% of its book value, a condition often associated with distressed assets or businesses with significant intangible or unrecorded liabilities. Similarly, EV/EBITDA data is unavailable, preventing an assessment of valuation relative to enterprise value and operating earnings. Regarding trading range, the 52-week high and low are both $0.06, meaning the stock has been trading at $0.00 below the 52-week high and low, effectively showing zero range movement within the past year. The beta value is 1.48, which indicates that the stock's price volatility is 48% higher than the broader market, suggesting that price movements will be amplified during periods of market fluctuation.

Growth & Income

The company experienced a revenue decline of 22.1% year-over-year, while earnings growth is not applicable (N/A) due to the reported net losses. Since earnings are negative, a comparison of growth rates between revenue and earnings is not feasible, but the contraction in revenue suggests a shrinking top line or loss of major industrial clients in the pharmaceutical and semiconductor sectors. The company does not pay dividends, as evidenced by a dividend yield and payout ratio that are not applicable, meaning all available cash is retained within the entity or used to service debt and operational costs. This non-dividend profile reflects a strategy focused on survival and potential future reinvestment rather than current income distribution to shareholders. Overall, the growth and income profile is characterized by negative revenue momentum, significant cash burn, and the absence of dividend distributions, presenting a challenging environment for income-seeking investors.